Effect of uric acid on gentamicin-induced nephrotoxicity in rats - Role of matrix metalloproteinases 2 and 9

Basic and Clinical Pharmacology and Toxicology

Volumn 105, Issue 6, 2009, Pages 416-424

  Romero, Freddy ^a   Pérez, Mariela ^a   Chávez, Maribel ^b   Parra, Gustavo ^b   Durante, Paula ^a  

^a IVIC Zulia   (Venezuela)

^b UNIVERSIDAD DEL ZULIA   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; GELATINASE A; GELATINASE B; GENTAMICIN; MALONALDEHYDE; URIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; BLOOD SAMPLING; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOWN REGULATION; HISTOLOGY; KIDNEY; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; RAT; SCORING SYSTEM; UREA NITROGEN BLOOD LEVEL; URIC ACID URINE LEVEL; URINALYSIS; WESTERN BLOTTING; ZYMOGRAPHY;

ANIMALS; ANTI-BACTERIAL AGENTS; GENTAMICINS; KIDNEY; KIDNEY FUNCTION TESTS; KIDNEY TUBULAR NECROSIS, ACUTE; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; OXIDATIVE STRESS; PROTEINURIA; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RENAL INSUFFICIENCY; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TIME FACTORS; URIC ACID;

RATTUS;

EID: 70449639936     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2009.00466.x     Document Type: Article

References (47)

1. Mingeot-Leclercq MP, Tulkens P. Aminoglycosides: nephrotoxicity. Antimicrob Agents Chemother 1999 43 : 1003 1012.
2. Ali BH. Agents ameliorating or augmenting experimental gentamicin nephrotoxicity: some recent research. Food Chem Toxicol 2003 41 : 1447 1452.
3. Nony P, Schnelmann R. Mechanisms of renal cell repair and regeneration after acute renal failure. J Pharmacol Exp Ther 2003 304 : 905 912.
4. Lelongt B, Legallicier B, Piedagnel R, Ronco P. Do matrix metalloproteinases MMP-2 and MMP-9 (gelatinases) play a role in renal development, physiology and glomerular diseases? Curr Opin Nephrol Hypertens 2001 10 : 7 12.
5. Ejaz AA, Mu W, Kang D, Roncal C, Sautin YY, Henderson G et al. Could uric acid have a role in acute renal failure? Clin J Am Soc Nephrol 2007 2 : 16 21.
6. Ames BN, Cathcart R, Schwiers E, Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci USA 1981 73 : 6858 6862.
7. Becker BF. Towards the physiological function of uric acid. Free Radic Biol Med 1993 14 : 615 631.
8. Scott GS, Hooper DC. The role of uric acid in protection against peroxynitrite-mediated pathology. Med Hypotheses 2001 56 : 95 100.
9. Du Y, Chen C, Tseng CY, Eisenberg Y. Astroglia mediated effects of uric acid to protect spinal cord neurons from glutamate toxicity. GLIA 2007 55 : 463 472.
10. Hooper DC, Scott GS, Zborek A, Mikheeva T, Kean RB, Koprowski H et al. Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood - CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosis. FASEB J 2000 14 : 691 698.
11. Zare F, Magnusson M, Bergström T, Brisslert M, Josefsson E, Karlsson A et al. Uric acid, a nucleic acid degradation product, down-regulates dsRNA-triggered arthritis. J Leukoc Biol 2006 79 : 482 488.
12. Hooper DC, Spitsin S, Kean RB, Champion JM, Dickson GM, Chaudhry I et al. Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis. Proc Natl Acad Sci USA 1998 95 : 675 680.
13. Kastenbauer S, Koedel U, Becker BF, Pfister HW. Experimental meningitis in the rat: protection by uric acid at human physiological blood concentrations. Eur J Pharmacol 2001 425 : 149 152.
14. Patschan D, Patschan S, Gobe G, Chintala S, Goligorsky M. Uric acid heralds ischemic tissue injury to mobilize endothelial progenitor cells. J Am Soc Nephrol 2007 18 : 1516 1524.
15. Roncal C, Mu W, Croker B, Reungjui S, Ouyang X, Tabah-Fisch I et al. Effect of elevated serum uric acid on cisplatin-induced acute renal failure. Am J Physiol Renal Physiol 2007 292 : F116 22.
16. Han HJ, Lim MJ, Lee YJ, Lee JH, Yang IS, Taub M. Uric acid inhibits renal proximal tubule cell proliferation via at least two signaling pathways involving PKC, MAPK, cPLA2, and NF-κB. Am J Physiol Renal Physiol 2007 292 : F373 81.
17. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979 95 : 351 358.
18. Vercauteren SR, Ysebaert DK, De Greef KE, Eyskens EJ, De Broe ME. Chronic reduction in renal mass in the rat attenuates Ischemia/Reperfusion injury and does not impair tubular regeneration. J Am Soc Nephrol 1999 10 : 2551 2561.
19. Ben-Ismail TH, Ali BH, Bashir AA. Influence of iron, deferoxamine and ascorbic acid on gentamicin-induced nephrotoxicity in rats. Gen Pharmacol 1994 25 : 1249 1252.
20. Fashola TO, Obatomi DK, Plummer DT. The combined effect of cyclosporine and gentamicin on enzymuria in the Sprague-Dawley rats. Ren Fail 2000 22 : 283 295.
21. Ali BH. Serum angiotensin-converting enzyme activity in rats with gentamicin-induced nephrotoxicity. Nephron 1993 64 : 477 478.
22. Ali BH, Bashir AA, Tanira MO. The effect of thyroxine or carbimazole treatment on gentamicin nephrotoxicity in rats. Human Exp Toxicol 1995 14 : 13 7.
23. Muñoz-Castañeda JR, Montilla P, Muñoz M, Bujalance I, Muntané J, Túnez I. Parachlorophenylalanine exacerbates oxidative stress induced by gentamicin in rats. Basic Clin Pharmacol Toxicol 2005 97 : 174 178.
24. Safirstein R, Miller P, Kahn T. Cortical and papillary absorptive defects in Gentamicin nephrotoxicity. Kidney Int 1983 24 : 526 533.
25. Adelman RD, Spangler WL, Beason F, Ishizaki G, Conzelman R. Furosemide enhancement of experimental gentamicin nephrotoxicity: comparison of functional and morphological changes with activities of urinary enzymes. J Infect Dis 1979 140 : 342 352.
26. Ali BH, Al-Qarawj AA, Mahmoud OM, Hashad M. Influence of spironolactone treatment on gentamicin-induced nephrotoxicity in rats. Basic Clin Pharmacol Toxicol 2004 95 : 20 3.
27. +- ATPase in rat kidney cells. Acta Physiol Scand 1991 141 : 27 34.
28. +- ATPase activity in rat striatum by the metabolites accumulated in Lesch-Nyhan disease. Int J Devl Neuroscience 2004 22 : 11 7.
29. Walker PD, Barri Y, Shah SV. Oxidant mechanisms in gentamicin nephrotoxicity. Ren Fail 1999 21 : 433 442.
30. Kadkhodaee M, Khastar H, Faghihi M, Ghaznavi R, Zahmatkesh M. Effects of co-supplementation of vitamins E and C on gentamicin-induced nephrotoxicity in rat. Exp Physiol 2005 90 : 571 576.
31. Kumar K, Naidu M, Shifow A, Ratnakar K. Probucol protects against gentamicin-induced nephrotoxicity in rats. Indian J Pharmacol 2000 32 : 108 113. (Pubitemid 30232335)
32. Silan C, Uzun Ö, çomunoǧlu N, Gokçen S, Bedihan S, Cengiz M. Gentamicin-induced nephrotoxicity in rats ameliorated and healing effects of Resveratrol. Biol Pharm Bull 2007 30 : 79 83.
33. Erdem A, Gündoǧan N, Usubütün A, Kilinç K, Erdem R, Kara A et al. The protective effect of taurine against gentamicin-induced acute tubular necrosis in rats. Nephrol Dial Transplant 2000 15 : 1175 1182.
34. Pedraza-Chaverrí J, Barrera D, Maldonado P, Chirino Y, Macías-Ruvalcaba N, Medina-Campos O et al. S-allylmercaptocysteine scavenges hydroxyl radical and singlet oxygen in vitro and attenuates gentamicin-induced oxidative and nitrosative stress and renal damage in vivo. BMC Clin Pharmacol 2004 4 : 5.
35. Karahan I, Ateşşahin A, Yilmaz S, Ceribaşi AO, Sakin F. Protective effect of lycopene on gentamicin-induced oxidative stress and nephrotoxicity in rats. Toxicology 2005 215 : 198 204. (Pubitemid 41446322)
36. Karataş Y, Seçilmiş MA, Karayaylali I, Doran F, Büyükafşar K, Singirik E et al. Effect of tempol (4-hydroxy tempo) on gentamicin- induced nephrotoxicity in rats. Fundam Clin Phapmacol 2004 18 : 79 83.
37. Shifow AA, Kumar KV, Naidu MU, Ratnakar KS. Melatonin, a pineal hormone with antioxidant property, protects against gentamicin-induced nephrotoxicity in rats. Nephron 2000 85 : 167 174.
38. Du XH, Yang CL. Mechanism of gentamicin nephrotoxicity in rats and the protective effect of zinc-induced metallothionenin synthesis. Nephrol Dial Transplant 1994 9 : 135 140.
39. Houghton DC, Hartnett M, Campbell-Boswell M, Porter G, Bennett W. A light and electron microscopic analysis of gentamicin nephrotoxicity in rats. Am J Pathol 1976 82 : 589 612.
40. Nonclercq D, Wrona S, Toubeau G, Zanen J, Heuson-Stiennon JA, Schaudies RP et al. Tubular injury and regeneration in the rat kidney following acute exposure to gentamicin: a time-course study. Ren Fail 1992 14 : 507 521.
41. Catania J, Chen G, Parrish A. Role of matrix metalloproteinases in renalpathophysiologies. Am J Physiol Renal Physiol 2007 292 : F905 11.
42. Piedagnel R, Murphy G, Ronco PM, Lelongt B. Matrix metalloproteinase 2 (MMP2) and MMP9 are produced by kidney collecting duct principal cells but are differentially regulated by SV40 large-T, arginine vasopressin, and epidermal growth factor. J Biol Chem 1999 274 : 1614 1620.
43. Cheng S, Pollock A, Mahimkar R, Olson J, Lovett D. Matrix metalloproteinase 2 and basement membrane integrity: a unifying mechanism for progressive renal injury. FASEB J 2006 20 : E1248 56.
44. Moreau D. Pharmacological treatment of acute renal failure in intensive care unit patients. Contrib Nephrol 2005 147 : 161 173.
45. Hencz P, Deverall PB, Crew AD, Steel AE, Mearns AJ. Hyperuricemia of infants and children: a complication of open heart surgery. J Pediatr 1979 94 : 774 776.
46. Johnson RJ, Segal MS, Sautin Y, Nakagawa T, Feig DI, Kang DH et al. Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic síndrome, diabetes, kidney disease, and cardiovascular disease. Am J Clin Nutr 2007 86 : 899 906.
47. Reyes AJ. Cardiovascular drugs and uric acid. Cardiovasc Drugs Ther 2003 17 : 397 414.